Lung Adenocarcinoma Clinical Trials in Beijing, Beijing Municipality
2 recruitingBeijing, Beijing Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients with Advanced Lung Adenocarcinoma
Advanced Lung Adenocarcinoma；Adult
Grit Biotechnology12 enrolled1 locationNCT06491225
Recruiting
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
Lung CancerLung AdenocarcinomaLung Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences60,000 enrolled1 locationNCT06255197